The Global Prevalence of HTLV-1 and HTLV-2 Infections among Immigrants and Refugees-A Systematic Review and Meta-Analysis
- PMID: 39459861
- PMCID: PMC11512286
- DOI: 10.3390/v16101526
The Global Prevalence of HTLV-1 and HTLV-2 Infections among Immigrants and Refugees-A Systematic Review and Meta-Analysis
Abstract
This is the first systematic review and meta-analysis to estimate the prevalence of human T-lymphotropic virus 1 and 2 (HTLV-1 and 2) infections among immigrants and refugees worldwide. PubMed/MEDLINE, Scopus, EMBASE, Web of Science, and Virtual Health Library (VHL) databases were searched for studies published from their inception to 6 January 2023. A meta-analysis using a generalized linear mixed model with a random effect was performed for HTLV-1 and HTLV-2. Subgroup analyses were performed based on the decade of study, sample size, confirmatory methods, region of study, risk group, and region of origin. Of the 381 studies initially identified, 21 were included. The pooled prevalence of HTLV-1 and HTLV-2 was 1.28% (95% CI: 0.58, 2.81) and 0.11% (95% CI: 0.04, 0.33), respectively. HTLV-1 prevalence differed significantly by region of origin, with the highest prevalence among those from the Western Pacific Region (7.27%; 95% CI: 2.94, 16.83). The subgroup analysis also showed significant differences between the estimates of HTLV-1 considering the decade of study, sample size, and region of study. For HTLV-2, significant differences were shown in relation to sample size, confirmatory methods, and risk group. The higher HTLV-1 prevalence found deserves public health attention in immigrant and refugee-receiving non-endemic countries.
Keywords: HTLV-1; HTLV-2; immigrant; meta-analysis; prevalence; refugee; systematic review.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures
References
-
- World Health Organization . Human T-Lymphotropic Virus Type 1. WHO; Geneva, Switzerland: 2023. [(accessed on 23 July 2024)]. Available online: https://www.who.int/news-room/fact-sheets/detail/human-t-lymphotropic-vi....
-
- WHO . Human T-Lymphotropic Virus Type 1: Technical Report. World Health Organization; Geneva, Switzerland: 2020. [(accessed on 1 July 2024)]. pp. 1–67. Available online: https://apps.who.int/iris/handle/10665/339773.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
